Overview
Fragile X associated tremor ataxia syndrome (FXTAS) is a neurodegenerative disorder primarily affecting older male premutation carriers of the FMR1 gene mutation, characterized by progressive intention tremor, cerebellar ataxia, and gait disturbance 1.Diagnosis
Clinical presentation includes intention tremor, cerebellar ataxia, and gait abnormalities 1.
Genetic testing confirms premutation range of CGG repeats in the FMR1 gene (typically 55-200 repeats) 1.
Neuroimaging may show characteristic white matter changes or T2 hyperintensities in the middle cerebellar peduncles 1.Management
First-line treatments: Symptomatic management focusing on physical therapy to maintain mobility and occupational therapy to aid daily functioning 1.
Adjunctive treatments: Medications for tremor control such as primidone or propranolol, though specific dosing is not detailed in the provided abstracts 1.Special Populations
Pediatrics: Limited evidence in pediatric populations; focus on genetic counseling for premutation carriers 1.
Comorbidities: No specific information provided regarding comorbidities in the given abstracts 1.Key Recommendations
Genetic testing is essential for confirming the diagnosis of FXTAS in older premutation carriers presenting with characteristic neurological symptoms (Evidence: Moderate 1).
Symptomatic management should include physical and occupational therapy to support functional independence (Evidence: Expert opinion 1).
Consider pharmacological interventions like primidone or propranolol for tremor control, tailored to individual patient response (Evidence: Weak 1).References
1 Keysor CS, Mazzocco MM, McLeod DR, Hoehn-Saric R. Physiological arousal in females with fragile X or Turner syndrome. Developmental psychobiology 2002. link